Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Biogen’s Aduhelm Crashes the Biotech Sector
Tickers BIIB NVS VTRS
Tags NVS NASDAQ:BIIB,NASDAQ:VTRS,NYSE:NVS, Market News
From InvestorPlace
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Tickers AGLE ALPN ATNM BDSX
Tags Small Cap Biotech Offerings
From Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
Tickers ABBV AMGN CANF NVS
Tags NVS Partner Content Biotech
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
Tickers CO DYNT NVS OVID
Tags Market News DYNT QURE
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
Tickers AGLE ALPN BCYC BTAI
Tags GRCL REGN Market News
From Benzinga
3 Things About Pfizer That Smart Investors Know
Tickers ABBV AZN BMY GSK
Tags PFE MRK Market News
From Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
Tickers BIIB BLUE GILD IBB
Tags BIIB MRNA NVS
From InvestorPlace
Novartis' Breast Cancer PI3K Drug, Scores FDA Approval For Ultra-Rare Indication
Tickers NVS
Tags FDA Benzinga Market News
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags STSA SRRK Penny Stocks
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
Tickers NVS
Tags Market News multiple sclerosis Benzinga
From Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Tickers ACAD ARGX ATRA BMY
Tags Market News Penny Stocks ISBC
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
Tickers ABBV ALNY AMGN APTX
Tags NVS ALNY IBB
From InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
Tickers AAPL CRRFY FRCOY MMM
Tags News NVS Top Stories
From Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
Tickers NVS
Tags Management Health Care General
From Benzinga
3 CEOs to Invest In
Tickers ANTM AXSM AZN GH
Tags Recent Press Releases AZN IMCR
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
Tickers ABBV AKBA ALNY AMRX
Tags AXSM Top Stories General
From Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
Tickers ACMR AMGN BABA BGNE
Tags ZLAB YUMC HCM
From InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Tickers ADMP AFIB AFMD AGRX
Tags AMPE BIOC Benzinga
From Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Tickers AZN GRFS GSK JNJ
Tags AZN MRNA SRNE
From Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
Tickers NVS
Tags Benzinga Market News General
From Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Tickers INCY NVO NVS
Tags NVS Market News INCY
From Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
Tickers AMGN CANF NVS
Tags Penny Stocks AMGN Benzinga
From Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
Tickers NVS
Tags News Briefs Large Cap
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags News IMMP ELDN
From Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Tickers FUSN LNTH NVS PNT
Tags NVS Partner Content LNTH
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Tickers ADMP AGTC ANAB APTO
Tags ORIC ORPH IBB
From Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
Tickers BABA BYDDY CP FB
Tags Markets Top Stories GOOGL
From Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
Tickers NVS
Tags Russia/Ukraine War Market News Benzinga
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
Tickers AAPL AMC AZN BABA
Tags XE:BAYN DXY BABA
From MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Tickers NVS PFE VYGR
Tags Market News NVS VYGR
From Motley Fool
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.